These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 19127071

  • 1. Validation study of the OHIO Chamber in patients with Japanese cedar pollinosis.
    Hashiguchi K, Tang H, Fujita T, Suematsu K, Tsubaki S, Nagakura H, Kitajima S, Gotoh M, Okubo K.
    Int Arch Allergy Immunol; 2009; 149(2):141-9. PubMed ID: 19127071
    [Abstract] [Full Text] [Related]

  • 2. Preliminary study on Japanese cedar pollinosis in an artificial exposure chamber (OHIO Chamber).
    Hashiguchi K, Tang H, Fujita T, Tsubaki S, Fujita M, Suematsu K, Gotoh M, Okubo K.
    Allergol Int; 2007 Jun; 56(2):125-30. PubMed ID: 17384532
    [Abstract] [Full Text] [Related]

  • 3. Bepotastine besilate OD tablets suppress nasal symptoms caused by Japanese cedar pollen exposure in an artificial exposure chamber (OHIO Chamber).
    Hashiguchi K, Tang H, Fujita T, Suematsu K, Gotoh M, Okubo K.
    Expert Opin Pharmacother; 2009 Mar; 10(4):523-9. PubMed ID: 19216705
    [Abstract] [Full Text] [Related]

  • 4. Evaluating the effects of testing period on pollinosis symptoms using an allergen challenge chamber.
    Yuki A, Terada T, Ichihara T, Fujii K, Hyo S, Kawata R, Takenaka H.
    Allergol Int; 2011 Dec; 60(4):533-9. PubMed ID: 21918369
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit.
    Enomoto T, Lu HQ, Yin M, Sakoda T, Dake Y, Enomoto K, Ide T, Cheng L.
    J Investig Allergol Clin Immunol; 2009 Dec; 19(4):299-305. PubMed ID: 19639726
    [Abstract] [Full Text] [Related]

  • 6. The efficacy of early treatment of seasonal allergic rhinitis with benifuuki green tea containing O-methylated catechin before pollen exposure: an open randomized study.
    Maeda-Yamamoto M, Ema K, Monobe M, Shibuichi I, Shinoda Y, Yamamoto T, Fujisawa T.
    Allergol Int; 2009 Sep; 58(3):437-44. PubMed ID: 19542766
    [Abstract] [Full Text] [Related]

  • 7. Seasonal changes in antigen-specific T-helper clone sizes in patients with Japanese cedar pollinosis: a 2-year study.
    Horiguchi S, Tanaka Y, Uchida T, Chazono H, Ookawa T, Sakurai D, Okamoto Y.
    Clin Exp Allergy; 2008 Mar; 38(3):405-12. PubMed ID: 18070160
    [Abstract] [Full Text] [Related]

  • 8. High contribution contrast between the genes of eosinophil peroxidase and IL-4 receptor alpha-chain in Japanese cedar pollinosis.
    Nakamura H, Miyagawa K, Ogino K, Endo T, Imai T, Ozasa K, Motohashi Y, Matsuzaki I, Sasahara S, Hatta K, Eboshida A.
    J Allergy Clin Immunol; 2003 Dec; 112(6):1127-31. PubMed ID: 14657871
    [Abstract] [Full Text] [Related]

  • 9. Characteristics of the Chiba environmental challenge chamber.
    Hamasaki S, Okamoto Y, Yonekura S, Okuma Y, Sakurai T, Iinuma T, Yamamoto H, Sakurai D, Horiguchi S, Yokota M.
    Allergol Int; 2014 Mar; 63(1):41-50. PubMed ID: 24368583
    [Abstract] [Full Text] [Related]

  • 10. Effect of enzymatically modified isoquercitrin, a flavonoid, on symptoms of Japanese cedar pollinosis: a randomized double-blind placebo-controlled trial.
    Kawai M, Hirano T, Arimitsu J, Higa S, Kuwahara Y, Hagihara K, Shima Y, Narazaki M, Ogata A, Koyanagi M, Kai T, Shimizu R, Moriwaki M, Suzuki Y, Ogino S, Kawase I, Tanaka T.
    Int Arch Allergy Immunol; 2009 Mar; 149(4):359-68. PubMed ID: 19295240
    [Abstract] [Full Text] [Related]

  • 11. [Is the frequency of pre-seasonal manifestation in patients with Japanese cedar pollinosis so high?].
    Okuda M, Ohkubo K, Gotoh M, Ishida Y.
    Arerugi; 2005 Jul; 54(7):636-40. PubMed ID: 16229363
    [Abstract] [Full Text] [Related]

  • 12. Pranlukast dry syrup inhibits symptoms of Japanese cedar pollinosis in children using OHIO Chamber.
    Wakabayashi K, Hashiguchi K, Kanzaki S, Fujioka M, Tanaka N, Kawashima K, Suematsu K, Yamamotoya H, Iwasaki M, Gotoh M, Horibe S, Naito K, Okubo K.
    Allergy Asthma Proc; 2012 Jul; 33(1):102-9. PubMed ID: 22370535
    [Abstract] [Full Text] [Related]

  • 13. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Kunii N, Yamamoto H, Sakurai D, Hanazawa T.
    Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
    Okamoto Y, Okubo K, Yonekura S, Hashiguchi K, Goto M, Otsuka T, Murata T, Nakao Y, Kanazawa C, Nagakura H, Okawa T, Nakano K, Hisamitsu M, Kaneko S, Konno A.
    Int Arch Allergy Immunol; 2015 May; 166(3):177-88. PubMed ID: 25895909
    [Abstract] [Full Text] [Related]

  • 15. Re-treatment with omalizumab at one year interval for Japanese cedar pollen-induced seasonal allergic rhinitis is effective and well tolerated.
    Ogino S, Nagakura T, Okubo K, Sato N, Takahashi M, Ishikawa T.
    Int Arch Allergy Immunol; 2009 May; 149(3):239-45. PubMed ID: 19218816
    [Abstract] [Full Text] [Related]

  • 16. Preliminary study of a challenge test to the patients with Japanese cedar pollinosis using an environmental exposure unit.
    Ito K, Terada T, Yuki A, Ichihara T, Hyo S, Kawata R, Takenaka H, Amano K, Ishiguro T, Ro T.
    Auris Nasus Larynx; 2010 Dec; 37(6):694-9. PubMed ID: 20452157
    [Abstract] [Full Text] [Related]

  • 17. Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination.
    Ito Y, Takahashi Y, Fujita T, Fukuyama S.
    Auris Nasus Larynx; 1997 Apr; 24(2):163-70. PubMed ID: 9134139
    [Abstract] [Full Text] [Related]

  • 18. Changes in plasma TARC levels during Japanese cedar pollen season and relationships with symptom development.
    Xiao JZ, Kondo S, Takahashi N, Odamaki T, Iwabuchi N, Miyaji K, Iwatsuki K, Enomoto T.
    Int Arch Allergy Immunol; 2007 Apr; 144(2):123-7. PubMed ID: 17536220
    [Abstract] [Full Text] [Related]

  • 19. Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross-allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell level.
    Sone T, Dairiki K, Morikubo K, Shimizu K, Tsunoo H, Mori T, Kino K.
    Clin Exp Allergy; 2005 May; 35(5):664-71. PubMed ID: 15898991
    [Abstract] [Full Text] [Related]

  • 20. 'Benifuuki' green tea containing o-methylated catechin reduces symptoms of Japanese cedar pollinosis: a randomized, double-blind, placebo-controlled trial.
    Masuda S, Maeda-Yamamoto M, Usui S, Fujisawa T.
    Allergol Int; 2014 Jun; 63(2):211-7. PubMed ID: 24561771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.